Gene expression in the prefrontal cortex during adolescence: Implications for the onset of schizophrenia

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Harris, Laura W ^a   Lockstone, Helen E ^a   Khaitovich, Phillipp ^b   Weickert, Cynthia Shannon ^c   Webster, Maree J ^d   Bahn, Sabine ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MAX PLANCK INSTITUTE FOR EVOLUTIONARY ANTHROPOLOGY   (Germany)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Stanley Laboratory of Brain Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; 4 AMINOBUTYRIC ACID RECEPTOR; ACYL COENZYME A DEHYDROGENASE; ASPARTOACYLASE; CATECHOL METHYLTRANSFERASE; CLAUDIN 11; DYSBINDIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLUTAMATE RECEPTOR 5; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEU DIFFERENTIATION FACTOR; NEUROPEPTIDE; PLASMOLIPIN; PROTEIN; PROTEOLIPID PROTEIN 1; RGS4 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ADULT; ARTICLE; AUTOPSY; BRAIN DEVELOPMENT; BRAIN TISSUE; CHILD; CONTROLLED STUDY; DISC1 GENE; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC RISK; GRIN3A GENE; GRM4 GENE; HUMAN; HUMAN TISSUE; INFANT; MALE; MICROARRAY ANALYSIS; MOBP GENE; MPZL1 GENE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHIZOPHRENIA; SCHOOL CHILD;

EID: 67949114182     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-28     Document Type: Article

References (89)

1. Frontal lobe and cognitive development. JM Fuster, J Neurocytol 2002 31 3-5 373 385 10.1023/A:1024190429920 12815254
2. Dynamic mapping of human cortical development during childhood through early adulthood. N Gogtay JN Giedd L Lusk KM Hayashi D Greenstein AC Vaituzis TF Nugent 3rd DH Herman LS Clasen AW Toga, Proc Natl Acad Sci USA 2004 101 21 8174 8179 15148381 10.1073/pnas.0402680101
3. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. D Rice S Barone Jr, Environ Health Perspect 2000 108 Suppl 3 511 533 10852851 10.2307/3454543 (Pubitemid 30466179)
4. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. G Bartzokis M Beckson PH Lu KH Nuechterlein N Edwards J Mintz, Arch Gen Psychiatry 2001 58 5 461 465 10.1001/archpsyc.58.5.461 11343525 (Pubitemid 32411326)
5. Brain development during childhood and adolescence: a longitudinal MRI study. JN Giedd J Blumenthal NO Jeffries FX Castellanos H Liu A Zijdenbos T Paus AC Evans JL Rapoport, Nat Neurosci 1999 2 10 861 863 10.1038/13158 10491603
6. Mapping brain maturation and cognitive development during adolescence. T Paus, Trends Cogn Sci 2005 9 2 60 68 10.1016/j.tics.2004.12.008 15668098
7. Synaptogenesis in the prefrontal cortex of rhesus monkeys. JP Bourgeois PS Goldman-Rakic P Rakic, Cereb Cortex 1994 4 1 78 96 10.1093/cercor/4.1.78 8180493 (Pubitemid 24066074)
8. Regional differences in synaptogenesis in human cerebral cortex. PR Huttenlocher AS Dabholkar, J Comp Neurol 1997 387 2 167 178 10.1002/(SICI)1096- 9861(19971020)387:2<167::AID-CNE13.0.CO;2-Z 9336221 (Pubitemid 27430343)
9. Development of the adolescent brain: implications for executive function and social cognition. SJ Blakemore S Choudhury, J Child Psychol Psychiatry 2006 47 3-4 296 312 10.1111/j.1469-7610.2006.01611.x 16492261
10. Structural and functional brain development and its relation to cognitive development. BJ Casey JN Giedd KM Thomas, Biol Psychol 2000 54 1-3 241 257 10.1016/S0301-0511(00)00058-2 11035225
11. Adolescence: vulnerable period for stress-induced prefrontal cortical function? Introduction to part IV. AF Arnsten RM Shansky, Ann N Y Acad Sci 2004 1021 143 147 10.1196/annals.1308.017 15251883
12. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. DA Lewis, Neuropsychopharmacology 1997 16 6 385 398 10.1016/S0893-133X(96)00277-1 9165494
13. Development of cortical and subcortical brain structures in childhood and adolescence: a structural MRI study. ER Sowell DA Trauner A Gamst TL Jernigan, Dev Med Child Neurol 2002 44 1 4 16 10.1017/S0012162201001591 11811649 (Pubitemid 34051455)
14. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. FM Benes M Turtle Y Khan P Farol, Arch Gen Psychiatry 1994 51 6 477 484 8192550 (Pubitemid 24180494)
15. The myelogenetic cycles of regional maturation of the brain. PI Yakovlev AR Lecours, Regional Development of the Brain in Early Life Boston: Blackwell Scientific publications, Minkowski A, 1967 3 70
16. Ontogeny of the human central nervous system: what is happening when? VB de Graaf-Peters M Hadders-Algra, Early Hum Dev 2006 82 4 257 266 10.1016/j.earlhumdev.2005.10.013 16360292
17. Pubertal hormones organize the adolescent brain and behavior. CL Sisk JL Zehr, Front Neuroendocrinol 2005 26 3-4 163 174 10.1016/j.yfrne.2005.10.003 16309736
18. Discordant changes in cortical TrkC mRNA and protein during the human lifespan. S Beltaifa MJ Webster DL Ligons RJ Fatula MM Herman JE Kleinman CS Weickert, Eur J Neurosci 2005 21 9 2433 2444 10.1111/j.1460-9568.2005.04074.x 15932601
19. Age-related differences in glucocorticoid receptor mRNA levels in the human brain. WR Perlman MJ Webster MM Herman JE Kleinman CS Weickert, Neurobiol Aging 2007 28 3 447 458 10.1016/j.neurobiolaging.2006.01.010 16540204
20. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. EM Tunbridge CS Weickert JE Kleinman MM Herman J Chen BS Kolachana PJ Harrison DR Weinberger, Cereb Cortex 2007 17 5 1206 1212 10.1093/cercor/bhl032 16835293
21. Postnatal alterations in dopaminergic markers in the human prefrontal cortex. CS Weickert MJ Webster P Gondipalli D Rothmond RJ Fatula MM Herman JE Kleinman M Akil, Neuroscience 2007 144 3 1109 1119 10.1016/j.neuroscience.2006. 10.009 17123740
22. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood. LA Glantz JH Gilmore RM Hamer JA Lieberman LF Jarskog, Neuroscience 2007 149 3 582 591 17916412 10.1016/j.neuroscience.2007.06.036
23. Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. TB Romanczyk CS Weickert MJ Webster MM Herman M Akil JE Kleinman, Eur J Neurosci 2002 15 2 269 280 10.1046/j.0953-816x.2001.01858.x 11849294
24. BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. MJ Webster CS Weickert MM Herman JE Kleinman, Brain Res Dev Brain Res 2002 139 2 139 150 10.1016/S0165-3806(02)00540-0 12480128
25. Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. C Colantuoni TM Hyde S Mitkus A Joseph L Sartorius C Aguirre J Creswell E Johnson A Deep-Soboslay MM Herman, Brain Struct Funct 2008 213 1-2 255 271 10.1007/s00429-008-0181-5 18470533
26. Transcriptome analysis of male-female differences in prefrontal cortical development. CS Weickert M Elashoff AB Richards S Bahn D Sinclair S Paabo P Khaitovich MJ Webster, Mol Psychiatry 2009 19455171
27. Application and optimization of microarray technologies for human postmortem brain studies. MM Ryan SJ Huffaker MJ Webster M Wayland T Freeman S Bahn, Biol Psychiatry 2004 55 4 329 336 10.1016/j.biopsych.2003.10.016 14960284
28. Affymetrix. http://www.affymetrix.com
29. R: A language and environment for statistical computing. R Development Core Team, Vienna, Austria 2005
30. Bioconductor: open software development for computational biology and bioinformatics. RC Gentleman VJ Carey DM Bates B Bolstad M Dettling S Dudoit B Ellis L Gautier Y Ge J Gentry, Genome Biol 2004 5 10 R80 15461798 10.1186/gb-2004-5-10-r80
31. A microarray data analysis framework for postmortem tissues. ES Jackson MT Wayland W Fitzgerald S Bahn, Methods 2005 37 3 247 260 10.1016/j.ymeth.2005. 09.006 16308154
32. affyplm: methods for fitting probe level models to affy data. B Bolstad, Technical report 2004 http://www.bioconductor.org
33. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. RA Irizarry B Hobbs F Collin YD Beazer-Barclay KJ Antonellis U Scherf TP Speed, Biostatistics 2003 4 2 249 264 10.1093/biostatistics/4.2.249 12925520
34. The epidemiology of late-onset schizophrenia. DJ Castle RM Murray, Schizophr Bull 1993 19 4 691 700 8303220 (Pubitemid 23339427)
35. Dementia Praecox and Paraphrenia. E Kraeplin, Edinburgh: E. and S. Livingston 1919
36. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Y Benjamini Y Hochberg, Journal of the Royal Statistical Society B 1995 57 289 300
37. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. A Subramanian P Tamayo VK Mootha S Mukherjee BL Ebert MA Gillette A Paulovich SL Pomeroy TR Golub ES Lander, Proc Natl Acad Sci USA 2005 102 43 15545 15550 16199517 10.1073/pnas.0506580102
38. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. S Draghici P Khatri P Bhavsar A Shah SA Krawetz MA Tainsky, Nucleic Acids Res 2003 31 13 3775 3781 12824416 10.1093/nar/gkg624
39. The Gene Ontology (GO) project in 2006. Gene Ontology Consortium., Nucl Acids Res 2006 34 suppl-1 D322 326 10.1093/nar/gkj021
40. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. PJ Harrison AJ Law, Biol Psychiatry 2006 60 2 132 140 10.1016/j.biopsych.2005.11.002 16442083
41. An update on the genetics of schizophrenia. N Norton HJ Williams MJ Owen, Curr Opin Psychiatry 2006 19 2 158 164 10.1097/01.yco.0000214341.52249.59 16612196
42. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. R Hashimoto RE Straub CS Weickert TM Hyde JE Kleinman DR Weinberger, Mol Psychiatry 2004 9 3 299 307 10.1038/sj.mp.4001434 14569272
43. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. AJ Law BK Lipska CS Weickert TM Hyde RE Straub R Hashimoto PJ Harrison JE Kleinman DR Weinberger, Proc Natl Acad Sci USA 2006 103 17 6747 6752 16618933 10.1073/pnas.0602002103
44. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. T Beissbarth TP Speed, Bioinformatics 2004 20 9 1464 1465 10.1093/bioinformatics/bth088 14962934
45. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. D Tkachev ML Mimmack MM Ryan M Wayland T Freeman PB Jones M Starkey MJ Webster RH Yolken S Bahn, Lancet 2003 362 9386 798 805 10.1016/S0140-6736(03)14289-4 13678875
46. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. C Aston L Jiang BP Sokolov, J Neurosci Res 2004 77 6 858 866 10.1002/jnr.20208 15334603
47. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. S Dracheva KL Davis B Chin DA Woo J Schmeidler V Haroutunian, Neurobiol Dis 2006 21 3 531 540 10.1016/j.nbd.2005.08.012 16213148
48. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Y Hakak JR Walker C Li WH Wong KL Davis JD Buxbaum V Haroutunian AA Fienberg, Proc Natl Acad Sci USA 2001 98 8 4746 4751 11296301 10.1073/pnas.081071198
49. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. P Katsel KL Davis V Haroutunian, Schizophr Res 2005 79 2-3 157 173 10.1016/j.schres.2005.06. 007 16139990
50. Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. T Sugai M Kawamura S Iritani K Araki T Makifuchi C Imai R Nakamura A Kakita H Takahashi H Nawa, Ann N Y Acad Sci 2004 1025 84 91 10.1196/annals.1316.011 15542704
51. Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia. M Walterfang SJ Wood D Velakoulis C Pantelis, Neurosci Biobehav Rev 2006 30 7 918 948 10.1016/j.neubiorev.2006.02.001 16580728
52. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. D Tkachev ML Mimmack SJ Huffaker M Ryan S Bahn, Int J Neuropsychopharmacol 2007 10 4 557 63 10.1017/S1461145706007334 17291371
53. Validation of housekeeping genes for normalizing RNAexpression in real-time PCR. K Dheda JF Huggett SA Bustin MA Johnson G Rook A Zumla, Biotechniques 2004 37 1 112 114 116, 118-119 15283208
54. Changes in the expression of the NR2B subunit during aging in macaque monkeys. L Bai PR Hof DG Standaert Y Xing SE Nelson AB Young KR Magnusson, Neurobiol Aging 2004 25 2 201 208 10.1016/S0197-4580(03)00091-5 14749138
55. Development and aging of N-methyl-D-aspartate receptor expression in the prefrontal/frontal cortex of mice. T Ontl Y Xing L Bai E Kennedy S Nelson M Wakeman K Magnusson, Neuroscience 2004 123 2 467 479 10.1016/j.neuroscience. 2003.09.006 14698754
56. Neuroligins mediate excitatory and inhibitory synapse formation: involvement of PSD-95 and neurexin-1beta in neuroligin-induced synaptic specificity. JN Levinson N Chery K Huang TP Wong K Gerrow R Kang O Prange YT Wang A El-Husseini, J Biol Chem 2005 280 17 17312 17319 10.1074/jbc.M413812200 15723836
57. A critical period of brain development: studies of cerebral glucose utilization with PET. HT Chugani, Prev Med 1998 27 2 184 188 10.1006/pmed.1998.0274 9578992
58. Maturation of widely distributed brain function subserves cognitive development. B Luna KR Thulborn DP Munoz EP Merriam KE Garver NJ Minshew MS Keshavan CR Genovese WF Eddy JA Sweeney, Neuroimage 2001 13 5 786 793 10.1006/nimg.2000.0743 11304075
59. Effect of ATP depletion on the palmitoylation of myelin proteolipid protein in young and adult rats. OA Bizzozero P Sanchez SU Tetzloff, J Neurochem 1999 72 6 2610 2616 10.1046/j.1471-4159.1999.0722610.x 10349873
60. Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. LI Sanchez-Abarca A Tabernero JM Medina, Glia 2001 36 3 321 329 10.1002/glia.1119 11746769
61. Myelin under construction - teamwork required. T Boiko B Winckler, J Cell Biol 2006 172 6 799 801 16533942 10.1083/jcb.200602101
62. Membrane traffic in myelinating oligodendrocytes. EM Kramer A Schardt KA Nave, Microsc Res Tech 2001 52 6 656 671 10.1002/jemt.1050 11276118
63. Myelin biogenesis: vesicle transport in oligodendrocytes. JN Larocca AG Rodriguez-Gabin, Neurochem Res 2002 27 11 1313 1329 10.1023/A:1021667515030 12512937
64. Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites. K Trajkovic AS Dhaunchak JT Goncalves D Wenzel A Schneider G Bunt KA Nave M Simons, J Cell Biol 2006 172 6 937 948 16520383 10.1083/jcb.200509022
65. SNARE complex proteins, including the cognate pair VAMP-2 and syntaxin-4, are expressed in cultured oligodendrocytes. DL Madison WH Krueger D Cheng BD Trapp SE Pfeiffer, J Neurochem 1999 72 3 988 998 10.1046/j.1471-4159.1999. 0720988.x 10037470
66. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. GR Gordon DV Baimoukhametova SA Hewitt WR Rajapaksha TE Fisher JS Bains, Nat Neurosci 2005 8 8 1078 1086 10.1038/nn1498 15995701
67. TTF-1, a homeodomain gene required for diencephalic morphogenesis, is postnatally expressed in the neuroendocrine brain in a developmentally regulated and cell-specific fashion. BJ Lee GJ Cho RB Norgren Jr MP Junier DF Hill V Tapia ME Costa SR Ojeda, Mol Cell Neurosci 2001 17 1 107 126 10.1006/mcne.2000.0933 11161473
68. The Oct-2 POU domain gene in the neuroendocrine brain: a transcriptional regulator of mammalian puberty. SR Ojeda J Hill DF Hill ME Costa V Tapia A Cornea YJ Ma, Endocrinology 1999 140 8 3774 3789 10.1210/en.140.8.3774 10433239 (Pubitemid 30645435)
69. The neural basis of puberty and adolescence. CL Sisk DL Foster, Nat Neurosci 2004 7 10 1040 1047 10.1038/nn1326 15452575
70. The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. M Jaegle M Ghazvini W Mandemakers M Piirsoo S Driegen F Levavasseur S Raghoenath F Grosveld D Meijer, Genes Dev 2003 17 11 1380 1391 12782656 10.1101/gad.258203 (Pubitemid 36666007)
71. Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. DH Blackwood BJ Pickard PA Thomson KL Evans DJ Porteous WJ Muir, Neurotox Res 2007 11 1 73 83 17449450
72. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. I Bertram HG Bernstein U Lendeckel A Bukowska H Dobrowolny G Keilhoff D Kanakis C Mawrin H Bielau P Falkai, Ann N Y Acad Sci 2007 1096 147 156 10.1196/annals.1397.080 17405926
73. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. CG Hahn HY Wang DS Cho K Talbot RE Gur WH Berrettini K Bakshi J Kamins KE Borgmann-Winter SJ Siegel, Nat Med 2006 12 7 824 828 10.1038/nm1418 16767099
74. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. JJ Hill T Hashimoto DA Lewis, Mol Psychiatry 2006 11 6 557 566 10.1038/sj.mp.4001792 16402129
75. Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia. K Ikeda K Ikeda S Iritani H Ueno K Niizato, Prog Neuropsychopharmacol Biol Psychiatry 2004 28 2 379 383 10.1016/j.pnpbp.2003.11. 008 14751436
76. Increased tachykinin NK(1) receptor immunoreactivity in the prefrontal cortex in schizophrenia. PA Tooney VC Crawter LA Chahl, Biol Psychiatry 2001 49 6 523 527 10.1016/S0006-3223(00)01068-4 11257237
77. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. E Holmes TM Tsang JT Huang FM Leweke D Koethe CW Gerth BM Nolden S Gross D Schreiber JK Nicholson, PLoS Med 2006 3 8 e327 16933966 10.1371/journal.pmed.0030327
78. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. JT Huang FM Leweke D Oxley L Wang N Harris D Koethe CW Gerth BM Nolden S Gross D Schreiber, PLoS Med 2006 3 11 e428 17090210 10.1371/journal.pmed.0030428
79. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. S Prabakaran JE Swatton MM Ryan SJ Huffaker JT Huang JL Griffin M Wayland T Freeman F Dudbridge KS Lilley, Mol Psychiatry 2004 9 7 684 697 10.1038/sj.mp.4001532 15098003
80. Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients. TM Tsang JT Huang E Holmes S Bahn, J Proteome Res 2006 5 4 756 760 10.1021/pr0503782 16602681
81. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. CA Altar LW Jurata V Charles A Lemire P Liu Y Bukhman TA Young J Bullard H Yokoe MJ Webster, Biol Psychiatry 2005 58 2 85 96 10.1016/j.biopsych.2005.03.031 16038679
82. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. K Iwamoto M Bundo T Kato, Hum Mol Genet 2005 14 2 241 253 10.1093/hmg/ddi022 15563509
83. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. FA Middleton K Mirnics JN Pierri DA Lewis P Levitt, J Neurosci 2002 22 7 2718 2729 11923437 (Pubitemid 37465821)
84. Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders. WT Regenold P Phatak MA Kling P Hauser, Mol Psychiatry 2004 9 8 731 733 10.1038/sj.mp.4001517 15098005
85. Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. ML MacDonald A Naydenov M Chu D Matzilevich C Konradi, Bipolar Disord 2006 8 3 255 264 10.1111/j.1399-5618.2006.00302.x 16696827
86. Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. G Bartzokis, Neuropsychopharmacology 2002 27 4 672 683 10.1016/S0893-133X(02)00364-0 12377404
87. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. B Li RS Woo L Mei R Malinow, Neuron 2007 54 4 583 597 17521571 10.1016/j.neuron.2007.03.028
88. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. K Roy JC Murtie BF El-Khodor N Edgar SP Sardi BM Hooks M Benoit-Marand C Chen H Moore P O'Donnell, Proc Natl Acad Sci USA 2007 104 19 8131 8136 17483467 10.1073/pnas.0702157104
89. Neuregulin-1 enhances depolarization-induced GABA release. RS Woo XM Li Y Tao E Carpenter-Hyland YZ Huang J Weber H Neiswender XP Dong J Wu M Gassmann, Neuron 2007 54 4 599 610 10.1016/j.neuron.2007.04.009 17521572